- Home
- JANX vs HIFS Comparison
JANX vs HIFS Comparison
Compare JANX & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JANX | HIFS |
|---|---|---|
| Founded | 2017 | 1834 |
| Country | United States | United States |
| Employees | N/A | 92 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.3M | 682.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | JANX | HIFS |
|---|---|---|
| Price | $13.76 | $275.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $53.60 | N/A |
| AVG Volume (30 Days) | ★ 759.1K | 51.4K |
| Earning Date | 05-07-2026 | 04-10-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.63 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.12 | $209.71 |
| 52 Week High | $35.34 | $338.00 |
Technical Indicators
Market Signals| Indicator | JANX | HIFS |
|---|---|---|
| Relative Strength Index (RSI) | 49.58 | 44.62 |
| Support Level | $13.80 | $264.92 |
| Resistance Level | $14.44 | $296.37 |
| Average True Range (ATR) | 0.51 | 10.41 |
| MACD | -0.00 | 1.08 |
| Stochastic Oscillator | 39.09 | 43.85 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.